Memantine White Tablet (Memantine Hydrochloride)

Adult dose

This medication is taken orally once a day and should be administered at the same time every day. If necessary, it may be taken twice a day. The dosage increase schedule is as follows: - Week 1 (Days 1-7): 5 mg once daily - Week 2 (Days 8-14): 10 mg once daily - Week 3 (Days 15-21): 15 mg once daily - From Week 4: 20 mg once daily. The recommended maintenance dose is 20 mg once daily.

This medication should not be used in patients with allergic reactions to any of its components. Additionally, it is safe to avoid administering it to patients with very poor liver function or severely impaired kidney function. Caution should be taken when using it in patients with epilepsy or those with a history of seizures, and in patients at risk of developing seizures. When taken with other NMDA antagonists, side effects may worsen, so co-administration is not recommended. Patients with factors affecting urinary acidity (pH) should be carefully monitored. There is insufficient safety data for patients with heart disease or uncontrolled hypertension, so caution is necessary. While taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so symptoms should be closely monitored. Rarely, neurological symptoms such as mental confusion, hallucinations, and seizures may occur, so if any unusual symptoms arise, consultation with a physician is advised. This medication may interact with other drugs, so patients should inform their physician about any medications they are taking, especially when used with certain antipsychotics or antihypertensives. Women who are pregnant or may become pregnant should carefully consider the use of this medication as it may affect the fetus, and a discussion with a physician is recommended. If breastfeeding, it is recommended to discontinue breastfeeding as this medication may be transmitted in breast milk. Safety and efficacy in children and adolescents under 18 years of age have not been established. If an overdose occurs, central nervous system symptoms or gastrointestinal symptoms may appear, and prompt medical attention should be sought, as there is no specific antidote, and treatment will be symptomatic. Patients taking this medication should be cautious when driving or operating machinery, especially Alzheimer's patients who may experience a slowed reaction time, so safety should be prioritized. Finally, this medication should be kept out of the reach of children, and it is advisable not to transfer it to another container.

Serious side effects

• Seizures
• heart failure
• hypertension
• venous thromboembolism/thromboembolism
• respiratory distress
• pancreatitis
• elevated liver function test values
• hepatitis
• drug hypersensitivity

Mild side effects

• Dizziness
• headache
• constipation
• drowsiness
• confusion
• hallucinations
• psychotic reactions
• balance disorders
• gait abnormalities
• vomiting

This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This will help ensure the effectiveness of the medication over time.

Appearance

White elongated film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle